已收录 272983 条政策
 政策提纲
  • 暂无提纲
Animal models for COVID-19
[摘要] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19. The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] RESPIRATORY SYNDROME CORONAVIRUS;MOUSE MODEL;SARS;INFECTION;MICE;SARS-COV-2;MERS;PATHOGENESIS;RESERVOIRS;EFFICACY [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文